IGMS

IGM Biosciences
IGMS

Overview Fund Activity
Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

89 hedge funds and large institutions have $316M invested in IGM Biosciences in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
31
Reduced
26
Closed
19
Calls
$2M
Puts
$252K
Net Calls
+$1.75M
Net Calls Change
-$5.36M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$47.3M
2
Millennium Management
2
Millennium Management
New York
$10.6M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$4.56M
4
Victory Capital Management
4
Victory Capital Management
Texas
$1.47M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.58M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
EC
2
EcoR1 Capital
California
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.21M
4
Goldman Sachs
4
Goldman Sachs
New York
$3.58M
5
WP
5
Woodline Partners
California
$3.61M
Name Holding Trade Value Shares
Change 		Shares
Change %
ECM
101
ExodusPoint Capital Management
New York
– -$287K -10,728 Closed
CL
102
CSS LLC
Illinois
– -$275K -10,300 Closed
BC
103
Brookfield Corp
Ontario, Canada
– -$200K -7,500 Closed
Parallax Volatility Advisers
104
Parallax Volatility Advisers
California
– -$53K -1,962 Closed
IC
105
Ikarian Capital
Texas
– -$43K -1,587 Closed
CG
106
Cutler Group
California
– -$18K -700 Closed
QT
107
Quantbot Technologies
New York
– -$12K -460 Closed
Osaic Holdings
108
Osaic Holdings
Arizona
– -$5K -200 Closed
1 2 3 4
5